About us Alcobra Ltd., founded in 2008 and headquartered in Tel Aviv, Israel, is an emerging pharmaceutical company focused on the development of new medications to help patients with central nervous system disorders. The company’s lead investigational product candidate is an abuse deterrent formulation of amphetamine immediate release (ADAIR) for the treatment of ADHD.
| Org | Common People |
|---|---|
| Merck & Co. Inc. | David Baker-Philadelphia |
| Shire plc | David Baker-Philadelphia |
| Philadelphia Education Fund | David Baker-Philadelphia |
| Akili Interactive | David Baker-Philadelphia |
| Types | Organization |
| Start date | 2008 |